Should You Ever Wait to Treat Intracranial Hemorrhage in the Anticoagulated Patient?

/
program_726_final.jpg

As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding, or appropriately employing emergent options to manage major bleeding. Recent solutions for DOAC related life-threatening bleeding are under-recognized and under-utilized solutions for patients with these life-threatening emergencies. Over the last 12-18 months, nationally recognized guidelines have provided clear direction on how best to manage these types of major bleeding events. As data emerges regarding new approaches to therapy, clinicians need to be aware of these new and effective approaches and to assess the benefits and risks associated with each of these approaches. Education provided by experts from the EMCREG-International network within this program correctly and promptly address patient treatment approaches to the appropriate healthcare professionals.

This program will review appropriate diagnosis and monitoring of life-threatening bleeds, the latest clinical guidelines and data surrounding DOAC use, and recommendations on reversal agents in the emergent setting.

W. Brian Gibler, MD FACEP, FACC, FAHA
President, EMCREG-International
Professor of Emergency Medicine
Director of Business Development
Department of Emergency Medicine
University of Cincinnati College of Medicine
Cincinnati, OH

Natalie Kreitzer, MD, MS
Assistant Professor
Emergency Medicine and Neurocritical Care
University of Cincinnati
Cincinnati, OH

Aaron Grossman MD, PhD
Departments of Neurology and Neurosurgery
Co-Director, Comprehensive Stroke Center
University of Cincinnati
Cleveland, OH

Intracranial Hemorrhage in the Anticoagulated Patient: Should You Ever Wait to Treat in the Emergency Department or the ICU?

Restarting Anticoagulation in the Post-Stroke Patient   

Case Study: A 54-Year-Old Anticoagulated Male with a Cerebellar Hemorrhage

Should the Emergency Physician Require Neurological Specialist Approval To Treat ICH in the Emergency Department or ICU?